Become a Distributor

frovatriptan succinate monohydrate

Mutagenesis research chemicals - Frovatriptan Succinate Monohydrate causes vasoconstriction of arteries and veins that supply blood to the head. It is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Reference standards of Frovatriptan Succinate Monohydrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Acetate
    [catalogue_number] => PA 06 83560
    [category_ids] => ,79,71,104,
    [chemical_name] => 
    [weight] => 257.29
    [form] => C14H15N3O2
    [cas] => 72254-58-1
    [pslug] => 72254-58-1-3-amino-1-methyl-5h-pyrido-4-3-b-indole-acetate-pa0683560
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)